The value of local treatment in patients with primary, disseminated, multifocal Ewing sarcoma (PDMES) (Q84928460)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19924786%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

title

The value of local treatment in patients with primary, disseminated, multifocal Ewing sarcoma (PDMES) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19924786%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19924786%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

Julia Haeusler

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19924786%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Tobias Boelling

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19924786%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Georg Gosheger

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19924786%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Gabriele Braun-Munzinger

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19924786%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Volker Vieth

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19924786%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Stefan Burdach

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19924786%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Henk van den Berg

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19924786%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Heribert Juergens

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19924786%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Uta Dirksen

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19924786%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

publication date

1 January 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19924786%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19924786%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

volume

116

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19924786%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19924786%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

page(s)

443-450

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19924786%20AND%20SRC:MED&resulttype=core&format=json

The Ewing family of tumors. Ewing's sarcoma and primitive neuroectodermal tumors

12 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24740

7 January 2021

Multidisciplinary treatment of primary Ewing's sarcoma of bone. A 6-year experience of a European Cooperative Trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24740

7 January 2021

A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: end results of POG #8346. Pediatric Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24740

7 January 2021

Ewing's family of tumors in adults: multivariate analysis of survival and long-term results of multimodality therapy in 182 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24740

7 January 2021

Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24740

7 January 2021

Long-term results from the first UKCCSG Ewing's Tumour Study (ET-1). United Kingdom Children's Cancer Study Group (UKCCSG) and the Medical Research Council Bone Sarcoma Working Party

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24740

7 January 2021

Prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: the third study of the French Society of Paediatric Oncology (EW88 study)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24740

7 January 2021

A long-term review of the treatment of patients with Ewing's sarcoma in one institution.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24740

7 January 2021

Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24740

7 January 2021

Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies. European Intergroup Cooperative Ewing Sarcoma Studies.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24740

7 January 2021

Impact of high-dose busulfan plus melphalan as consolidation in metastatic Ewing tumors: a study by the Société Française des Cancers de l'Enfant.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24740

7 January 2021

Tandem high-dose chemotherapy with autologous peripheral hematopoietic progenitor cell rescue as consolidation therapy for patients with high-risk Ewing family tumors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24740

7 January 2021

High-dose therapy with hematopoietic stem cell rescue in patients with poor prognosis Ewing family tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24740

7 January 2021

Allogeneic and autologous stem-cell transplantation in advanced Ewing tumors. An update after long-term follow-up from two centers of the European Intergroup study EICESS. Stem-Cell Transplant Programs at Düsseldorf University Medical Center, German

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24740

7 January 2021

Treatment of Ewing sarcoma family of tumors: current status and outlook for the future

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24740

7 January 2021

Primitive neuroectodermal tumor and Ewing's sarcoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24740

7 January 2021

MIC2 is a specific marker for ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberrati

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24740

7 January 2021

The Ewing Family of Tumors -- A Subgroup of Small-Round-Cell Tumors Defined by Specific Chimeric Transcripts

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24740

7 January 2021

Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24740

7 January 2021

Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children's Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24740

7 January 2021

Local therapy and other factors influencing site of relapse in patients with localised Ewing's sarcoma. United Kingdom Children's Cancer Study Group (UKCCSG)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24740

7 January 2021

Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24740

7 January 2021

Long-Term Follow-Up and Prognostic Factors in Ewing’s Sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24740

7 January 2021

Five-year results in Ewing's sarcoma. The Scandinavian Sarcoma Group experience with the SSG IX protocol

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24740

7 January 2021

Ewing's sarcoma metastatic at diagnosis. Results and comparisons of two intergroup Ewing's sarcoma studies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24740

7 January 2021

Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24740

7 January 2021

Significant benefit of multimodal imaging: PET/CT compared with PET alone in staging and follow-up of patients with Ewing tumors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24740

7 January 2021

FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24740

7 January 2021

Successful high-resolution animal positron emission tomography of human Ewing tumours and their metastases in a murine xenograft model

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24740

7 January 2021

[18F]Fluorodeoxyglucose positron emission tomography predicts outcome for Ewing sarcoma family of tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24740

7 January 2021

Identifiers

DOI

10.1002/CNCR.24740

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19924786%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference